Applications, impacts and consequences of botulinum toxin usage in medicine
DOI:
https://doi.org/10.12775/JEHS.2024.70.55709Keywords
neurotoxin, botulinum toxin, botulism, Clostridium botulinum, botulinum toxin treatmentsAbstract
Introduction
Botulinum toxin is a neurotoxin produced by the gram-positive bacteria Clostridium botulinum. Botulinum toxin has found great interest in the field of aesthetic medicine, but it has many other applications in other areas of medicine.
Aim of the study
The aim of this comprehensive review is to provide an overview of the usage of botulinum toxin in medicine, with a focus on specific areas of medicine. Attention will be paid to the safety of the use of this substance, taking into account its molecular structure and mechanism of action.
Materials and methods
An analysis of the scientific articles available in the Pubmed, Google Scholar and web of science databases was performed. Recent publications which most appropriately encompassed the issues under discussion have been selected for the purpose of this study. The process of search was carried out with the following keywords: neurotoxin, botulinum toxins, botulism, muscle paralysis.
Summary
Despite numerous studies, there is ample room for further research into the safety of using botulinum toxin in patients as well as new therapies with this substance. Botulinum toxin is a neurotoxin that is widely used in medicine, but has many side effects.
References
Patricia T Ting, Anatoli Freiman, The story of Clostridium botulinum: from food poisoning to Botox, Clinical Medicine, Volume 4, Issue 3, 2004, Pages 258-261, ISSN 1470-2118, https://doi.org/10.7861/clinmedicine.4-3-258.
Christiane G. Frick, Martina Richtsfeld, Nita D. Sahani, Masao Kaneki, Manfred Blobner, J A. Jeevendra Martyn; Long-term Effects of Botulinum Toxin on Neuromuscular Function. Anesthesiology 2007; 106:1139–1146 doi: https://doi.org/10.1097/01.anes.0000267597.65120.16
Rempel, L.; Malik, R.N.; Shackleton, C.; Calderón-Juárez, M.; Sachdeva, R.; Krassioukov, A.V. From Toxin to Treatment: A Narrative Review on the Use of Botulinum Toxin for Autonomic Dysfunction. Toxins 2024, 16, 96. https://doi.org/10.3390/toxins16020096
Frank J. Erbguth MD, PhD: Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin. First published: 09 March 2004 https://doi.org/10.1002/mds.20003
Palazón-García, R.; Benavente-Valdepeñas, A.M. Botulinum Toxin: From Poison to Possible Treatment for Spasticity in Spinal Cord Injury. Int. J. Mol. Sci. 2021, 22, 4886. https://doi.org/10.3390/ijms22094886
James G. Caya, MD; Rashmi Agni, MD; Joan E. Miller, BA: Clostridium botulinum and the Clinical Laboratorian: A Detailed Review of Botulism, Including Biological Warfare Ramifications of Botulinum Toxin. Arch Pathol Lab Med (2004) 128 (6): 653–662.
https://doi.org/10.5858/2004-128-653-CBATCL
Roberto Eleopra MD, Valeria Tugnoli MD, Rocco Quatrale MD, Ornella Rossetto PhD, Cesare Montecucco FP: Different types of botulinum toxin in humans. First published: 09 March 2004 https://doi.org/10.1002/mds.20010
R. L. Rosales, H. Bigalke, D. Dressler: Pharmacology of botulinum toxin: differences between type A preparations. First published: 15 September 2008 https://doi.org/10.1111/j.1468-1331.2006.01438.x
K. R. Aoki, B. Guyer: Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions. First published: 21 December 2001 https://doi.org/10.1046/j.1468-1331.2001.00035.x
Brandt, N., Flurie, R. (2020). Acetylcholine. In: Gellman, M.D. (eds) Encyclopedia of Behavioral Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-39903-0_1351
Safety of botulinum toxin type A in children younger than 2 years. Pascual-Pascual, Samuel Ignacio et al. European Journal of Paediatric Neurology, Volume 13, Issue 6, 511 - 515 https://doi.org/10.1016/j.ejpn.2008.10.006
Stephen K. Fisher, Susan Wonnacott, Chapter 13 - Acetylcholine, Editor(s): Scott T. Brady, George J. Siegel, R. Wayne Albers, Donald L. Price, Basic Neurochemistry (Eighth Edition), Academic Press, 2012, Pages 258-282, ISBN 9780123749475, https://doi.org/10.1016/B978-0-12-374947-5.00013-4
Dirk Dressler, Fereshte Adib Saberi; Botulinum Toxin: Mechanisms of Action. Eur Neurol 1 March 2005; 53 (1): 3–9. https://doi.org/10.1159/000083259
Boris Bentsianov, Craig Zalvan, Andrew Blitzer, Noncosmetic uses of botulinum toxin, Clinics in Dermatology, Volume 22, Issue 1, 2004, Pages 82-88, ISSN 0738-081X, https://doi.org/10.1016/j.clindermatol.2003.12.030
Pickett, A.; Perrow, K. Towards New Uses of Botulinum Toxin as a Novel Therapeutic Tool. Toxins 2011, 3, 63-81.https://doi.org/10.3390/toxins3010063
Botulinum toxin treatment for facial palsy: A systematic review Cooper, Lilli et al. Journal of Plastic, Reconstructive & Aesthetic Surgery, Volume 70, Issue 6, 833 - 841
https://doi.org/10.1016/j.bjps.2017.01.009
Jun JY, Park JH, Youn CS, Lee JH. Intradermal Injection of Botulinum Toxin: A Safer Treatment Modality for Forehead Wrinkles. Ann Dermatol. 2018 Aug;30(4):458-461. https://doi.org/10.5021/ad.2018.30.4.458
Laskawi, R. The use of botulinum toxin in head and face medicine: An interdisciplinary field. Head Face Med 4, 5 (2008). https://doi.org/10.1186/1746-160X-4-5
Maik Ellies MD, Rainer Laskawi MD, Saskia Rohrbach-Volland MD, Christian Arglebe PhD, Wolfgang Beuche MD: Botulinum Toxin to Reduce Saliva Flow: Selected Indications for Ultrasound-Guided Toxin Application Into Salivary Glands First published: 02 January 2009 https://doi.org/10.1097/00005537-200201000-00015
Cavallini M, Cirillo P, Fundarò SP, Quartucci S, Sciuto C, Sito G, Tonini D, Trocchi G, Signorini M. Safety of botulinum toxin A in aesthetic treatments: a systematic review of clinical studies. Dermatol Surg. 2014 May;40(5):525-36. doi: 10.1111/dsu.12463. Epub 2014 Feb 28. PMID: 24575858.
S M Reid MClinEpi BAppSc (physio), B R Johnstone MB BS FRACS, C Westbury RN, B Rawicki FAFRM FRACP, D S Reddihough MD BSc FRACP FAFRM: Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders. First published: 14 January 2008 https://doi.org/10.1111/j.0012-1622.2008.02010.x
Oliver P Kreyden, E.Paul Scheidegger, Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis, Clinics in Dermatology, Volume 22, Issue 1, 2004, Pages 40-44, ISSN 0738-081X,
https://doi.org/10.1016/j.clindermatol.2003.12.029
F. Gilio MD, A. Currà MD, C. Lorenzano MD, N. Modugno MD, M. Manfredi MD, A. Berardelli MD: Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia. First published: 27 March 2001 https://doi.org/10.1002/1531-8249(200007)48:1<20::AID-ANA5>3.0.CO;2-U
Bledsoe IO, Comella CL. Botulinum Toxin Treatment of Cervical Dystonia. Semin Neurol. 2016 Feb;36(1):47-53. doi: 10.1055/s-0035-1571210. Epub 2016 Feb 11. PMID: 26866496.
Aurora S, Dodick D, Turkel C, et al. OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia. 2010;30(7):793-803. doi:10.1177/0333102410364676
Diener H, Dodick D, Aurora S, et al. OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010;30(7):804-814. doi:10.1177/0333102410364677
Ion, I.; Renard, D.; Le Floch, A.; De Verdal, M.; Bouly, S.; Wacongne, A.; Lozza, A.; Castelnovo, G. Monocentric Prospective Study into the Sustained Effect of Incobotulinumtoxin A (XEOMIN®) Botulinum Toxin in Chronic Refractory Migraine. Toxins 2018, 10, 221. https://doi.org/10.3390/toxins10060221
Herd CP, Tomlinson CL, Rick C, Scotton WJ, Edwards J, Ives N, Clarke CE, Sinclair A. Botulinum toxins for the prevention of migraine in adults. Cochrane Database of Systematic Reviews 2018, Issue 6. Art. No.: CD011616. DOI: 10.1002/14651858.CD011616.pub2. Accessed 19 October 2024.
Felber, Eric S.. "Botulinum Toxin in Primary Care Medicine" Journal of Osteopathic Medicine, vol. 106, no. 10, 2006, pp. 609-614. https://doi.org/10.7556/jaoa.2006.106.10.609
Başar E, Arıcı C. Use of Botulinum Neurotoxin in Ophthalmology. Turk J Ophthalmol. 2016 Dec;46(6):282-290. doi:10.4274/tjo.57701.
Botulinum Toxin Injection for the Treatment of Strabismus Binenbaum, Gil et al. Ophthalmology, Volume 128, Issue 12, 1766 - 1776 https://doi.org/10.1016/j.ophtha.2021.05.009
Jiang, YH., Liao, CH. & Kuo, HC. Current and potential urological applications of botulinum toxin A. Nat Rev Urol 12, 519–533 (2015). https://doi.org/10.1038/nrurol.2015.193
Lin, Y.-H.; Chiang, B.-J.; Liao, C.-H. Mechanism of Action of Botulinum Toxin A in Treatment of Functional Urological Disorders. Toxins 2020, 12, 129. https://doi.org/10.3390/toxins12020129
Kuo, H.-C. Botulinum Toxin Brings a Light to the Shadow of Functional Urology. Toxins 2023, 15, 321. https://doi.org/10.3390/toxins15050321
Tinastepe, N., Küçük, B. B., & Oral, K. (2015). Botulinum toxin for the treatment of bruxism. CRANIO®, 33(4), 292–299. https://doi.org/10.1179/2151090314Y.0000000022
Fernández-Núñez T, Amghar-Maach S, Gay-Escoda C. Efficacy of botulinum toxin in the treatment of bruxism: Systematic review. Med Oral Patol Oral Cir Bucal. 2019 Jul 1;24(4):e416-e424. doi: 10.4317/medoral.22923. PMID: 31246937; PMCID: PMC6667018.
TREATING SEVERE BRUXISM WITH BOTULINUM TOXIN TAN, ENG-KING et al. The Journal of the American Dental Association, Volume 131, Issue 2, 211 - 216 https://doi.org/10.14219/jada.archive.2000.0149
Hu Long, Zhengyu Liao, Yan Wang, Lina Liao, Wenli Lai, Efficacy of botulinum toxins on bruxism: an evidence-based review, International Dental Journal, Volume 62, Issue 1, 2012, Pages 1-5, ISSN 0020-6539, https://doi.org/10.1111/j.1875-595X.2011.00085.x.
Lee, Seung Jin DDS, MSD; McCall, Willard D. Jr PhD; Kim, Young Ku DDS, PhD; Chung, Sung Chang DDS, PhD; Chung, Jin Woo DDS, PhD. Effect of Botulinum Toxin Injection on Nocturnal Bruxism: A Randomized Controlled Trial. American Journal of Physical Medicine & Rehabilitation 89(1):p 16-23, January 2010. | DOI:10.1097/PHM.0b013e3181bc0c78
Naumann, M., & Jankovic, J. (2004). Safety of botulinum toxin type A: a systematic review and meta-analysis. Current Medical Research and Opinion, 20(7), 981–990. https://doi.org/10.1185/030079904125003962
M. Naumann, A. Albanese, F. Heinen, G. Molenaers, M. Relja: Safety and efficacy of botulinum toxin type A following long-term use. First published: 13 November 2006 https://doi.org/10.1111/j.1468-1331.2006.01652.x
Nicte I. Mejia MD, Kevin Dat Vuong MA, Joseph Jankovic MD: Long-term botulinum toxin efficacy, safety, and immunogenicity. First published: 11 January 2005 https://doi.org/10.1002/mds.20376
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Weronika Kiełt, Julia Kozłowska, Gabriela Broniec, Barbara Wajdowicz, Aleksandra Kudła, Rozalia Czapiewska, Aleksandra Dziewulska, Aleksandra Wróbel, Laura Pacek, Klaudia Kowalska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 237
Number of citations: 0
